HSP90 drives the Rab11a-mediated vesicular transport of the cell surface receptors in osteoclasts

Area of Science:

• Cell Biology
• Molecular Biology
• Biochemistry

Background:

• Rab11a regulates vesicular transport and acts as a negative regulator of osteoclastogenesis by degrading c-fms and RANK receptors.
• The molecular mechanisms underlying Rab11a's inhibitory role in osteoclastogenesis were previously unclear.
• Heat shock protein 90 (HSP90) is crucial for protein stability, signaling pathways, and vesicular transport, with known roles in osteoclast modulation via Rab11b.

Purpose of the Study:

• To investigate the molecular mechanisms by which Rab11a negatively regulates osteoclastogenesis.
• To determine the interaction between Rab11a and HSP90 isoforms (HSP90α and HSP90β) in osteoclasts.
• To elucidate the role of HSP90 in mediating Rab11a's inhibitory effects on osteoclast differentiation and function.

Main Methods:

• Investigated the interaction between Rab11a and HSP90α/β in osteoclasts (OCs).
• Utilized a specific HSP90 ATPase inhibitor (17-allylamino-demethoxygeldanamycin) to block HSP90 activity.
• Assessed the impact of HSP90 inhibition on the interaction between HSP90 and Rab11a, and its effect on osteoclastogenesis.

Main Results:

• Rab11a was found to interact with both HSP90α and HSP90β in osteoclasts.
• The ATPase domain of HSP90 is essential for its interaction with Rab11a.
• The interaction between HSP90 and Rab11a is sufficient to maintain Rab11a's inhibitory effects on osteoclastogenesis.

Conclusions:

• Heat shock protein 90 (HSP90) plays a novel role in regulating Rab11a-mediated osteoclastogenesis.
• HSP90's interaction with Rab11a is critical for inhibiting osteoclast differentiation, maturation, and bone-resorbing activity.
• These findings reveal a new regulatory pathway involving HSP90 and Rab11a in bone remodeling.